ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666850; 2) Community: the network communities that were significantly associated with the response to NSC 666850; 3) Molecule: the relationships between components within communities and NSC 666850; 4) MDR: the compounds that were significantly associated with the NSC 666850.

NSC Compound Enrichment Correlation
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.00423163567577551 0.59915924
NSC 2805 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl 0.00423163567577551 0.52848905
NSC 282159 EN 589 0.00423163567577551 0.35832379
NSC 289074 Null 0.00423163567577551 0.67179485
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.00423163567577551 0.13540184
NSC 302991 Camptothecin Derivative 0.00423163567577551 0.031327778
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.00423163567577551 0.62699916
NSC 364830 Camptothecin Derivative 0.00423163567577551 -0.016034453
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.00423163567577551 0.57661974
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.00423163567577551 0.60846265
Total:103  Current:16    [First] [Prev] [Next] [Last]